Manufacturer ProfileAPINEXA Verified

Teva API

Teva Active Pharmaceutical Ingredients Division

Global API division of Teva Pharmaceuticals — one of the world's largest API portfolios with deep regulatory coverage and CDMO depth across 17 sites.

Headquarters
Petah Tikva, Israel
Established
1935 · 91 years
Company Type
API Manufacturer · CDMO · Exporter
Region
Tel Aviv · EMEA
Compliance Coverage
USFDAEU GMPEDQMCEPDMFPMDA
Verification & Trust

Pre-qualified, Compliance-Reviewed Supplier

APINEXA verifies every manufacturer for compliance, regulatory documentation availability, and active export capability before listing.

APINEXA Verified
Confirmed
Verified since Feb 2024
Compliance Review
Cleared
Documentation reviewed by APINEXA team
Export Status
Active
Supplying 168 countries
Match Score
95
AI-derived sourcing confidence
Documentation Availability

Audit-grade documentation pack

  • DMF Available
    Drug Master File on request via NDA
  • CEP Support
    EDQM Certificate of Suitability
  • COA per Batch
    Certificate of Analysis with every shipment
  • Stability Data
    ICH Q1A long-term stability available
  • Audit Report
    Recent third-party audit findings
All Certifications
USFDA
USFDA Site Inspection
U.S. Food & Drug Administration
EU
EU GMP Certification
European Medicines Agency
EDQM
EDQM Compliance
European Directorate for the Quality of Medicines
CEP
Certificate of Suitability
EDQM
DMF
US Drug Master File
USFDA
PMDA
PMDA Approval
Pharmaceuticals & Medical Devices Agency, Japan
Company Overview

About Teva API

Teva API is the API division of Teva Pharmaceutical Industries, supplying APIs and intermediates to generic, branded and innovator pharmaceutical companies globally. With one of the broadest API portfolios in the industry and significant R&D investment, Teva API operates 17 manufacturing facilities across Europe, North America and Asia, all maintained under stringent USFDA, EU GMP and EDQM regulatory oversight.

Specialization
Generic API PortfolioCustom SynthesisPeptidesSterile APIsSteroids & Hormones
Core Strengths

Why buyers choose them

  • One of the broadest API portfolios globally (312+)
  • CDMO depth with end-to-end services
  • Strong USFDA / EMA / EDQM compliance posture
  • European manufacturing base for EU buyers
Manufacturing Capabilities

Operational strength

Production capacity, technology platforms, and clean-room infrastructure verified at the manufacturer source.

Production Capacity

Large scale · 2,000 MT/yr

Batch size
1 kg pilot · 5,000 kg commercial
Annual capacity
2,000+ MT/year aggregate
Commercial scale
Tier-1 multi-site commercial scale
Facility Footprint

17 manufacturing sites

Plants
17
Manufacturing blocks
18 blocks
Clean-room classes
ISO 5 Clean Room · Sterile Block · ISO 7 Clean Room · Containment Suite
Technology Capabilities

Process technology

  • Peptide synthesis
  • HPAPI handling (OEB 4-5)
  • Sterile crystallization
  • Continuous manufacturing
  • Complex hormones
Regulatory Coverage

Export readiness across regulated markets

Authority-by-authority regulatory standing for major regulated and semi-regulated pharmaceutical markets.

Total Markets
6
Approved
6
Coverage
100%
RegionAuthorityStatus
United States
USFDAApproved
Europe
EU GMP / EDQMApproved
Japan
PMDAApproved
Canada
Health CanadaApproved
Australia
TGAApproved
Israel
MOH IsraelApproved
Export Markets

Active exports across 168 countries

Live supply footprint grouped by market regulatory class — Regulated, Semi-Regulated, and Emerging.

Regulated Markets
8
  • United States
  • Germany
  • United Kingdom
  • France
  • Italy
  • Japan
  • Canada
  • Australia
Semi-Regulated Markets
0

No countries in this category.

Emerging Markets
0

No countries in this category.

Export Statistics

168 countries · 8 highlighted

Active commercial exports across regulated markets, with documentation packs available per region.

🇺🇸🇩🇪🇬🇧🇫🇷🇮🇹🇯🇵🇨🇦🇦🇺
Facility & Infrastructure

Production sites & supporting infrastructure

Each facility is verified for clean-room class, production blocks, and built-up area.

Manufacturing Site

Teva API – Sicor Site

Rho, Italy

Blocks
7
Area
240,000 sq.ft
Classification
ISO 5 Clean RoomSterile Block
Manufacturing Site

Teva API – Plantex

Netanya, Israel

Blocks
5
Area
180,000 sq.ft
Classification
ISO 7 Clean RoomContainment Suite
Manufacturing Site

Teva API – Ramat Hovav

Beersheba, Israel

Blocks
6
Area
210,000 sq.ft
Classification
ISO 7 Clean Room
Supporting Infrastructure

R&D, QC, Warehousing & Stability

  • Global R&D centres (Israel + Italy)
  • USFDA & EMA inspected QC laboratories
  • GLP-compliant stability storage
  • Audit-grade documentation vault
Supply Capabilities

Procurement decision support

MOQ flexibility, lead times, packaging formats, and supply-flexibility signals to support procurement teams.

MOQ & Lead Time

Order flexibility

Minimum order quantity
1 kg pilot · 50 kg commercial
Lead time
4 – 8 weeks
Contract manufacturing
Supported
Long-term supply
Multi-year contracts
Packaging Options

Standard packaging formats

  • 25 kg fibre drums
    Validated packaging meeting export-grade requirements.
  • HDPE drums with PE liner
    Validated packaging meeting export-grade requirements.
  • Custom sterile packaging
    Validated packaging meeting export-grade requirements.
Certifications & Documents

Downloadable documentation pack

Secure document access. Restricted documents require an NDA submitted through the RFQ form.

  • GMP
    EU GMP Certificate – Italy site
    Active · 310 KB
    Download
  • CEP
    EDQM CEP Master Index
    Active · 680 KB
    Download
  • DMF
    US DMF Consolidated ListingNDA
    Active · 920 KB
    Request
  • TDS
    Teva API Portfolio 2026
    v9.1 · 4.5 MB
    Download
RFQ / Supplier Contact

Contact Teva API

Send a structured inquiry routed through APINEXA's coordination team — confidential, compliance-pre-checked, audit-grade. Typical response in 6 hours.

Confidential. Only the APINEXA sourcing team sees this submission.

Teva API
Petah Tikva, Israel · < 6 hours
Request Contact